ivosenidib

Browsing: ivosenidib

Conferences

ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AML

June 2, 2020

A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was…

Subscribe for News Updates
Search Oncology News
Search for:
Speak your mind!

Passionate about a development that deserves more attention? Views on a controversial issue?

Oncology News publishes commentary pieces from oncology professionals here and in The Oncology Newsletter.

Contact us to discuss
Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.
© Oncology News Australia | info@oncologynews.com.au